Does the IL1B rs16944 AG genotype increase IL-1β production and amplify inflammatory responses?

The IL1B rs16944 polymorphism, a single nucleotide polymorphism (SNP) located in the promoter region of the interleukin-1 beta gene, plays a critical role in modulating the body’s inflammatory response. The AG genotype (associated with the -511 T allele) is recognized in genetic research for its influence on cytokine signaling.

Genetic Regulation and Cytokine Production

• Research indicates that the IL1B rs16944 AG genotype is associated with increased transcriptional activity of the IL1B gene.
• In vitro and ex vivo studies demonstrate that cells from individuals with the AG genotype produce significantly higher levels of IL-1beta mRNA and protein compared to the AA genotype.
• Specifically, after stimulation with triggers like lipopolysaccharides (LPS), the AG genotype often results in a more robust and rapid secretion of this potent pro-inflammatory cytokine.

Clinical Impact and Persistent Triggers

• The AG genotype is linked to an amplified inflammatory response when the immune system is faced with persistent or severe triggers.
• In chronic inflammatory diseases, such as chronic osteomyelitis, the AG genotype has been identified as a significant risk factor for increased disease susceptibility and sustained inflammation.
• Studies in the context of COVID-19 have shown that individuals with the AG genotype may have a nearly twofold increased risk of hospitalization, likely due to an exaggerated "cytokine storm" response.
• Mechanistically, the G (or T) allele ensures a higher baseline of pro-IL-1beta, which the NLRP3 inflammasome can rapidly convert to active IL-1beta upon detecting persistent pathogens or cellular stress.

Bottom line

The IL1B rs16944 AG genotype is scientifically supported as a factor that increases IL-1beta production and predisposes individuals to exaggerated inflammatory responses. This genetic profile serves as a marker for heightened sensitivity to chronic or intense immune triggers, potentially increasing the risk for hyperinflammatory conditions.